Pure Global AI
NCT06312345Recruiting

Ciprofol Versus Propofol for Anesthesia Induction in Cardiac Surgery: A Randomized Double-blind Controlled Clinical Trial

Le YuClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Anesthesia
Drug/Device/Intervention
Drug: ciprofol injection
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Le Yu
Funder
Shanghai East Hospital of Tongji University
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Mar 11, 2024
End date
May 10, 2024
Enrollment
80 participants
Primary outcome

Mean arterial pressure,Mean arterial pressure,Mean arterial pressure,Mean arterial pressure,Heart beats,Heart beats,Heart beats,Heart beats

Summary

Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol,
 boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of
 injection pain, and minor impact on the cardiovascular system. However, clinical research
 regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsLocal anaestheticsOther complications of anaesthesiaComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06312345
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06312345 through Pure Global AI's free database. This phase not specified trial is sponsored by Le Yu and is currently Recruiting. The study focuses on Anesthesia. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.